Double attack on SARS

August 28, 2012
Double attack on SARS
© Thinkstock

After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order to develop preventive and therapeutic measures for SARS.

Despite the fatality of the SARS-CoV outbreak in Asia, the rising and quarantine measures managed to contain viral spread. However, it is believed that the SARS-CoV has not been fully eradicated and as a result, a vaccine as well as an immediate and effective are much needed.

To this end, scientists on the EU-funded 'Immunoprevention and immunotherapy of SARS infection' (Sarsvac) project proposed to follow a vaccination approach coupled with an immunotherapeutic regimen.

More specifically, the strategy for vaccine development consisted of two parallel approaches: the preparation of a classical vaccine made with attenuated SARS-CoV and the identification of potentially immunogenic viral antigens. These antigens were planned to be expressed in a vector-based vaccine for generating specific immunity against the virus.

Additionally, partners studied SARS-CoV–derived virus-like particles (VLPs) in order to understand the morphogenesis and maturation of virions. The information they obtained allowed them to identify specific epitopes that offered protective T and B cell-mediated immunity.

As an immunotherapeutic strategy, neutralising to SARS-CoV were developed and validated. The plan was to administer these as a treatment option to patients already infected with the virus.

The Sarsvac approach promises an immediate and long-term protection against a potential SARS-CoV infection. Commercial exploitation of this vaccine and immunotherapy combination may prove the solution against a future SARS-CoV outbreak.

Related Stories

Recommended for you

Ebola linked to habitat destruction

February 20, 2017

A Massey University veterinary scientist has co-authored research suggesting that Ebola virus emergence is linked to the clearing of animal habitat through deforestation in West and Central Africa.

New study determines how long Zika remains in body fluids

February 20, 2017

A study published in the New England Journal of Medicine provides evidence that the Zika virus particles remain longer in blood than in urine and some other body fluids. This information suggests that blood serum may be the ...

Researcher helps stem the spread of superbugs

February 20, 2017

Katherine Baker feels vindicated. She and other microbiologists have been warning for years that anti-bacterial soaps containing triclosan are bad for the environment, harmful for health, and do nothing to prevent disease.

Scientists uncover how Zika virus causes microcephaly

February 17, 2017

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered the mechanisms that the Zika virus uses to alter brain development. These findings are detailed in Stem Cell Reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.